Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1114

1.

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015.

Bauer M, Severus E, Köhler S, Whybrow PC, Angst J, Möller HJ; Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders.

World J Biol Psychiatry. 2015 Feb;16(2):76-95. doi: 10.3109/15622975.2014.1001786.

PMID:
25677972
[PubMed - in process]
2.

Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival.

Rødgaard-Hansen S, Rafique A, Weis N, Wejse C, Nielsen H, Pedersen SS, Møller HJ, Kronborg G.

Infect Dis (Lond). 2015 Feb 4:1-6. [Epub ahead of print]

PMID:
25650730
[PubMed - as supplied by publisher]
3.

Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus.

Sørensen LP, Parkner T, Søndergaard E, Bibby BM, Møller HJ, Nielsen S.

Endocr Connect. 2015 Mar;4(1):27-36. doi: 10.1530/EC-14-0107.

PMID:
25624106
[PubMed]
Free Article
4.

MelanA-negative spindle-cell associated melanoma, a distinct inflammatory phenotype correlated with dense infiltration of CD163 macrophages and loss of E-cadherin.

Bønnelykke-Behrndtz ML, Steiniche T, Damsgaard TE, Georgsen JB, Danielsen A, Bastholt L, Møller HJ, Nørgaard PH, Schmidt H.

Melanoma Res. 2015 Apr;25(2):113-8. doi: 10.1097/CMR.0000000000000138.

PMID:
25602697
[PubMed - in process]
5.

Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.

Möller HJ, Demyttenaere K, Olausson B, Szamosi J, Wilson E, Hosford D, Dunbar G, Tummala R, Eriksson H.

World J Biol Psychiatry. 2015 Jan 20:1-19. [Epub ahead of print]

PMID:
25602163
[PubMed - as supplied by publisher]
6.

Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy.

Fountoulakis KN, Gonda X, Baghai TC, Baldwin DS, Bauer M, Blier P, Gattaz W, Hasler G, Möller HJ, Tandon R, Vieta E, Kasper S.

Int J Psychiatry Clin Pract. 2014 Dec 30:1-29. [Epub ahead of print]

PMID:
25547437
[PubMed - as supplied by publisher]
7.

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

Schennach R, Riedel M, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Eur Psychiatry. 2015 Jan;30(1):43-50. doi: 10.1016/j.eurpsy.2014.11.001. Epub 2014 Dec 22.

PMID:
25541347
[PubMed - in process]
8.

HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study.

Knudsen A, Hag AM, Loft A, von Benzon E, Keller SH, Møller HJ, Lebech AM, Ripa RS, Kjær A.

J Nucl Cardiol. 2014 Dec 3. [Epub ahead of print]

PMID:
25467249
[PubMed - as supplied by publisher]
9.

Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders.

Köhler S, Wiethoff K, Ricken R, Stamm T, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Zeiler J, Heinz A, Bauer M, Adli M.

J Affect Disord. 2015 Mar;173:126-33. doi: 10.1016/j.jad.2014.10.059. Epub 2014 Nov 10.

PMID:
25462406
[PubMed - in process]
10.

Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.

Popp J, Wolfsgruber S, Heuser I, Peters O, Hüll M, Schröder J, Möller HJ, Lewczuk P, Schneider A, Jahn H, Luckhaus C, Perneczky R, Frölich L, Wagner M, Maier W, Wiltfang J, Kornhuber J, Jessen F.

Neurobiol Aging. 2015 Feb;36(2):601-7. doi: 10.1016/j.neurobiolaging.2014.10.031. Epub 2014 Oct 31.

PMID:
25435336
[PubMed - in process]
11.

Securing the future of drug discovery for central nervous system disorders.

Andersen PH, Moscicki R, Sahakian B, Quirion R, Krishnan R, Race T, Phillips A; 2013 CINP Summit Group.

Nat Rev Drug Discov. 2014 Dec;13(12):871-2. doi: 10.1038/nrd4489.

PMID:
25435203
[PubMed - indexed for MEDLINE]
12.

Prognostic stratification of ulcerated melanoma: not only the extent matters.

Bønnelykke-Behrndtz ML, Schmidt H, Christensen IJ, Damsgaard TE, Møller HJ, Bastholt L, Nørgaard PH, Steiniche T.

Am J Clin Pathol. 2014 Dec;142(6):845-56. doi: 10.1309/AJCPW56PHGLFTKZC.

PMID:
25389339
[PubMed - indexed for MEDLINE]
13.

Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass.

Fjeldborg K, Pedersen SB, Møller HJ, Rask P, Danielsen AV, Stødkilde-Jørgensen H, Richelsen B.

Obesity (Silver Spring). 2015 Jan;23(1):154-61. doi: 10.1002/oby.20942. Epub 2014 Nov 5.

PMID:
25376508
[PubMed - in process]
14.

Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.

Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.

Scand J Immunol. 2014 Dec;80(6):417-23. doi: 10.1111/sji.12222.

PMID:
25346048
[PubMed - indexed for MEDLINE]
15.

[The significance of depot medication in the long-term-treatment of schizophrenia].

Kühn KU, Wiedemann K, Hellweg R, Möller HJ.

Fortschr Neurol Psychiatr. 2014 Oct;82(10):557-65. doi: 10.1055/s-0034-1385108. Epub 2014 Oct 9. German.

PMID:
25299626
[PubMed - in process]
16.

What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Schennach R, Riedel M, Obermeier M, Spellmann I, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2015 Mar;265(2):107-16. doi: 10.1007/s00406-014-0528-2. Epub 2014 Sep 27.

PMID:
25261210
[PubMed - in process]
17.

World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care.

Ihl R, Bunevicius R, Frölich L, Winblad B, Schneider LS, Dubois B, Burns A, Thibaut F, Kasper S, Möller HJ; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Dementia.

Int J Psychiatry Clin Pract. 2015 Mar;19(1):2-7. doi: 10.3109/13651501.2014.961931. Epub 2014 Oct 18.

PMID:
25195764
[PubMed - in process]
18.

Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.

Kallestrup M, Møller HJ, Tankisi H, Andersen H.

Diabet Med. 2015 Jan;32(1):54-61. doi: 10.1111/dme.12568. Epub 2014 Sep 18.

PMID:
25156085
[PubMed - in process]
19.

DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences-part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Möller HJ, Bandelow B, Bauer M, Hampel H, Herpertz SC, Soyka M, Barnikol UB, Lista S, Severus E, Maier W.

Eur Arch Psychiatry Clin Neurosci. 2015 Mar;265(2):87-106. doi: 10.1007/s00406-014-0521-9. Epub 2014 Aug 26.

PMID:
25155875
[PubMed - in process]
20.

Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study.

Sandahl TD, Grønbaek H, Møller HJ, Støy S, Thomsen KL, Dige AK, Agnholt J, Hamilton-Dutoit S, Thiel S, Vilstrup H.

Am J Gastroenterol. 2014 Nov;109(11):1749-56. doi: 10.1038/ajg.2014.262. Epub 2014 Aug 26.

PMID:
25155228
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk